Skip to main content

Market value of products made by national manufacturers decreased by 9% in 2014

27.03.2015.
 

Market value of products made by national manufacturers decreased by 9% in 2014

The data collected by the State Agency of Medicines (hereinafter - SAM) regarding operating results of medicines manufacturers indicate a decrease in the total turnover of the products of Latvian medicines manufacturers in 2014. The total value of manufactured products (medicines and other products) sold was 135 million Euros (without VAT), which was decreased by 9% in comparison with 2013. The majority of the manufactured products (90%) were exported, but 10% of the manufactured products were sold in the local market.

Furthermore, in 2014 the amount of medicines sold in Latvia decreased by 8% and the amount of exported medicines - by 3% in comparison with 2013.

In 2014 JSC "Olainfarm" took over as the number one medicines manufacturer with the amount of its products sold in the local market in Latvia and abroad having increased by 12% and 19% accordingly, thus, surpassing the JSC "Grindex" - the leader in the previous years.

Total turnover of Latvian medicines manufacturers1 in 2014

Company nameTurnover in Euros
(without VAT)
1Olainfarm JSC* 
2Grindeks JSC51 164 541
3Silvanols LTD* 
4Riga Pharmaceutical Plant JSC2 101 462
5Kalceks JSC1 277 677
6LMP LTD1 127 889
7AGA LTD943 188
8Baltic Therapeutic Service LTD* 
9Pharmidea LTD*  
10Homeopathy*  
Total (all licensed medicines manufacturers):135 374 686

_____________
1 Excluding medicines manufacturers, where the manufacturing activity is repackaging and import;

Companies marked with * did not agree to the publication of data.